Sol-Gel Technologies Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sol-Gel Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013288
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sol-Gel Technologies Ltd (Sol-Gel) is a developer and manufacturer of topical dermatological drug products. The company’s products include Cool Pearls anti acne kit which is a benzoyl peroxide-based acne regime at commercial stage; and SGT-VD-54 is a non-antibiotic topical drug for the treatment of type 2 papulopostular rosacea. Its lead product candidate vered is used for the treatment of papulopustular rosacea. Sol-Gel’s TWIN and SIRS-T is used for the treatment of acne vulgaris. The company offers products to various therapeutic areas such as acne vulgaris, rosacea and tinea pedis. It operates in pharmaceutical and skincare companies in the US. Sol-Gel is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sol-Gel Technologies Enters into Agreement with CMO 11
Sol-Gel Technologies Amended Development Agreement with Perrigo 12
Licensing Agreements 13
Douglas Pharma Enters into Licensing Agreement with Sol-Gel Technologies 13
Sol-Gel Technologies Enters Into Licensing Agreement With US-Based Pharma Company For Dermatologic Drug 14
Equity Offering 15
Sol-Gel Technologies Files Registration Statement for IPO for up to USD86.3 Million 15
Acquisition 16
Mori Arkin Plans to Acquire Sol-Gel for USD10 Million 16
Sol-Gel Technologies Ltd – Key Competitors 17
Sol-Gel Technologies Ltd – Key Employees 18
Sol-Gel Technologies Ltd – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sol-Gel Technologies Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sol-Gel Technologies Enters into Agreement with CMO 11
Sol-Gel Technologies Amended Development Agreement with Perrigo 12
Douglas Pharma Enters into Licensing Agreement with Sol-Gel Technologies 13
Sol-Gel Technologies Enters Into Licensing Agreement With US-Based Pharma Company For Dermatologic Drug 14
Sol-Gel Technologies Files Registration Statement for IPO for up to USD86.3 Million 15
Mori Arkin Plans to Acquire Sol-Gel for USD10 Million 16
Sol-Gel Technologies Ltd, Key Competitors 17
Sol-Gel Technologies Ltd, Key Employees 18

★海外企業調査レポート[Sol-Gel Technologies Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EMC Insurance Group Inc.:企業の戦略・SWOT・財務情報
    EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report Summary EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AnaMar AB:医療機器:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Sanquin Blood Supply Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Avanza Bank Holding AB:企業の戦略・SWOT・財務分析
    Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report Summary Avanza Bank Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • Clean Harbors Inc (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors Inc (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Caldera Health Ltd:製品パイプライン分析
    Summary Caldera Health Ltd (Caldera) is a medical device company that develops prostate cancer diagnostic tools. The company develops prostate cancer diagnostic tools to detect and monitor the cancer disease. It also develops proscanZ and auditor tests based on the enzyme linked immunoassays or ELIS …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Danubius Hotel And Spa Private Company Limited
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Bonus BioGroup Ltd (BONS):医療機器:M&Aディール及び事業提携情報
    Summary Bonus BioGroup Ltd (Bonus BioGroup), formerly Oceania advanced industries Ltd is a biotechnology company that supplies tissue-engineered viable bone grafts. The company operates in the field of tissue engineering and live bone transplantation. Its products include BonoFill injectable bone gr …
  • Kone Corporation:企業の戦略・SWOT・財務分析
    Kone Corporation - Strategy, SWOT and Corporate Finance Report Summary Kone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sangoma Technologies Corp (STC):企業の財務・戦略的SWOT分析
    Sangoma Technologies Corp (STC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Castle Brands Inc.:企業の戦略・SWOT・財務分析
    Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report Summary Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Meggitt Plc (MGGT):企業の財務・戦略的SWOT分析
    Meggitt Plc (MGGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The Hour Glass Ltd (AGS):企業の財務・戦略的SWOT分析
    The Hour Glass Ltd (AGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Triple Energy Ltd (TNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Triple Energy Ltd (Triple Energy) is an oil and gas company that explores for natural resources. The company invests in oil and gas projects in the conventional and unconventional sectors such as coal seam gas and shale oil and gas, along with power generation. It offers project such as CFT …
  • Xiangxue Pharmaceutical Co Ltd (300147):製薬・医療:M&Aディール及び事業提携情報
    Summary Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The company’s products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare suppleme …
  • China General Technology (Group) Holding Ltd:企業の戦略・SWOT・財務分析
    China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary China General Technology (Group) Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Al Kamil Power Company SAOG (KPCS):企業の財務・戦略的SWOT分析
    Al Kamil Power Company SAOG (KPCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆